Implementation of RFID Technology in the 3500 Series Genetic Analyzers; a System for Tracking Key Information in the Clinical Genetics Laboratory

Andy Felton received his PhD in 1992 from Oxford Polytechnic studying the development of new active ester methods to design synthetic peptide analagues of Epidermal Growth Factor. Andy has been with Applied Biosystems for 15 years, with responsibility for a variety of product areas including DNA Synthesis, Sample Preparation, Real Time PCR Systems and most recently the Capillary Electrophoresis business and has launched 6 major instrument systems for Applied Biosystems in that time.

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc.